Annual Cash & Cash Equivalents
$16.30 M
-$34.99 M-68.23%
December 31, 2022
Summary
- As of February 10, 2025, SRGA annual cash & cash equivalents is $16.30 million, with the most recent change of -$34.99 million (-68.23%) on December 31, 2022.
- During the last 3 years, SRGA annual cash & cash equivalents has risen by +$10.69 million (+190.57%).
Performance
SRGA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$22.43 M
+$6.13 M+37.65%
March 31, 2023
Summary
- As of February 10, 2025, SRGA quarterly cash and cash equivalents is $22.43 million, with the most recent change of +$6.13 million (+37.65%) on March 31, 2023.
- Over the past year, SRGA quarterly cash and cash equivalents has dropped by -$22.25 million (-49.80%).
Performance
SRGA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SRGA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.2% | -49.8% |
| 3 y3 years | +190.6% | +242.1% |
| 5 y5 years | -27.2% | +62.4% |
SRGA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.2% | at low | -56.3% | -38.3% |
| 5 y | 5-year | -68.2% | -65.6% | -76.6% | -90.1% |
| alltime | all time | -68.2% | -65.6% | -76.6% | -96.6% |
Surgalign Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $22.43 M(+37.6%) |
| Dec 2022 | $16.30 M(-68.2%) | $16.30 M(+17.7%) |
| Sep 2022 | - | $13.85 M(-52.8%) |
| Jun 2022 | - | $29.34 M(-34.3%) |
| Mar 2022 | - | $44.68 M(-12.9%) |
| Dec 2021 | $51.29 M(+16.7%) | $51.29 M(-25.0%) |
| Sep 2021 | - | $68.36 M(-1.3%) |
| Jun 2021 | - | $69.26 M(+8.6%) |
| Mar 2021 | - | $63.76 M(+45.0%) |
| Dec 2020 | $43.96 M(+683.9%) | $43.96 M(-54.1%) |
| Sep 2020 | - | $95.79 M(+4197.4%) |
| Jun 2020 | - | $2.23 M(-66.0%) |
| Mar 2020 | - | $6.56 M(+16.9%) |
| Dec 2019 | $5.61 M(-48.8%) | $5.61 M(+90.1%) |
| Sep 2019 | - | $2.95 M(-34.7%) |
| Jun 2019 | - | $4.52 M(-25.2%) |
| Mar 2019 | - | $6.04 M(-44.8%) |
| Dec 2018 | $10.95 M(-51.1%) | $10.95 M(+9.2%) |
| Sep 2018 | - | $10.02 M(-29.7%) |
| Jun 2018 | - | $14.25 M(+3.1%) |
| Mar 2018 | - | $13.81 M(-38.3%) |
| Dec 2017 | $22.38 M(+61.6%) | $22.38 M(+26.1%) |
| Sep 2017 | - | $17.74 M(+29.8%) |
| Jun 2017 | - | $13.68 M(-22.3%) |
| Mar 2017 | - | $17.60 M(+27.1%) |
| Dec 2016 | $13.85 M(+9.8%) | $13.85 M(+19.1%) |
| Sep 2016 | - | $11.62 M(-8.9%) |
| Jun 2016 | - | $12.75 M(+8.7%) |
| Mar 2016 | - | $11.73 M(-7.0%) |
| Dec 2015 | $12.61 M(-19.7%) | $12.61 M(+22.4%) |
| Sep 2015 | - | $10.31 M(-18.8%) |
| Jun 2015 | - | $12.70 M(+6.7%) |
| Mar 2015 | - | $11.90 M(-24.2%) |
| Dec 2014 | $15.70 M(-16.1%) | $15.70 M(+12.7%) |
| Sep 2014 | - | $13.93 M(-11.8%) |
| Jun 2014 | - | $15.80 M(+2.2%) |
| Mar 2014 | - | $15.46 M(-17.4%) |
| Dec 2013 | $18.72 M(-62.3%) | $18.72 M(+16.0%) |
| Sep 2013 | - | $16.14 M(-59.0%) |
| Jun 2013 | - | $39.39 M(+1.5%) |
| Mar 2013 | - | $38.80 M(-21.9%) |
| Dec 2012 | $49.70 M(+7.6%) | $49.70 M(-10.0%) |
| Sep 2012 | - | $55.24 M(+10.0%) |
| Jun 2012 | - | $50.23 M(+5.6%) |
| Mar 2012 | - | $47.59 M(+3.1%) |
| Dec 2011 | $46.18 M | $46.18 M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $44.70 M(+14.5%) |
| Jun 2011 | - | $39.05 M(+17.8%) |
| Mar 2011 | - | $33.15 M(+17.5%) |
| Dec 2010 | $28.21 M(+62.3%) | $28.21 M(+81.5%) |
| Sep 2010 | - | $15.55 M(-12.3%) |
| Jun 2010 | - | $17.73 M(+1.0%) |
| Mar 2010 | - | $17.55 M(+1.0%) |
| Dec 2009 | $17.38 M(-13.4%) | $17.38 M(-15.0%) |
| Sep 2009 | - | $20.44 M(+44.3%) |
| Jun 2009 | - | $14.17 M(+8.5%) |
| Mar 2009 | - | $13.06 M(-34.9%) |
| Dec 2008 | $20.08 M(+8.2%) | $20.08 M(-6.9%) |
| Sep 2008 | - | $21.56 M(+1.1%) |
| Jun 2008 | - | $21.33 M(+12.6%) |
| Mar 2008 | - | $18.94 M(+2.0%) |
| Dec 2007 | $18.56 M(+19.7%) | $18.56 M(-1.3%) |
| Sep 2007 | - | $18.80 M(+0.2%) |
| Jun 2007 | - | $18.77 M(+13.3%) |
| Mar 2007 | - | $16.57 M(+6.8%) |
| Dec 2006 | $15.51 M(-39.3%) | $15.51 M(-5.8%) |
| Sep 2006 | - | $16.47 M(-19.5%) |
| Jun 2006 | - | $20.45 M(-18.2%) |
| Mar 2006 | - | $24.99 M(-2.2%) |
| Dec 2005 | $25.56 M(+122.6%) | $25.56 M(+10.2%) |
| Sep 2005 | - | $23.20 M(+395.5%) |
| Jun 2005 | - | $4.68 M(-15.0%) |
| Mar 2005 | - | $5.51 M(-52.0%) |
| Dec 2004 | $11.48 M(+14.3%) | $11.48 M(+9.8%) |
| Sep 2004 | - | $10.46 M(-3.0%) |
| Jun 2004 | - | $10.78 M(-48.4%) |
| Mar 2004 | - | $20.88 M(+107.7%) |
| Dec 2003 | $10.05 M(+2.4%) | $10.05 M(+3.4%) |
| Sep 2003 | - | $9.72 M(+4.7%) |
| Jun 2003 | - | $9.29 M(+5.0%) |
| Mar 2003 | - | $8.85 M(-9.8%) |
| Dec 2002 | $9.81 M(-27.3%) | $9.81 M(+126.2%) |
| Sep 2002 | - | $4.34 M(-50.3%) |
| Jun 2002 | - | $8.73 M(+17.9%) |
| Mar 2002 | - | $7.41 M(-45.1%) |
| Dec 2001 | $13.50 M(-61.4%) | $13.50 M(-34.7%) |
| Sep 2001 | - | $20.68 M(-19.2%) |
| Jun 2001 | - | $25.59 M(-12.1%) |
| Mar 2001 | - | $29.13 M(-16.6%) |
| Dec 2000 | $34.94 M(+363.7%) | $34.94 M(+23.2%) |
| Sep 2000 | - | $28.37 M(+3618.7%) |
| Jun 2000 | - | $762.90 K |
| Dec 1999 | $7.54 M | - |
FAQ
- What is Surgalign Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Surgalign Holdings?
- What is Surgalign Holdings annual cash & cash equivalents year-on-year change?
- What is Surgalign Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Surgalign Holdings?
- What is Surgalign Holdings quarterly cash and cash equivalents year-on-year change?
What is Surgalign Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of SRGA is $16.30 M
What is the all time high annual cash & cash equivalents for Surgalign Holdings?
Surgalign Holdings all-time high annual cash & cash equivalents is $51.29 M
What is Surgalign Holdings annual cash & cash equivalents year-on-year change?
Over the past year, SRGA annual cash & cash equivalents has changed by -$34.99 M (-68.23%)
What is Surgalign Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SRGA is $22.43 M
What is the all time high quarterly cash and cash equivalents for Surgalign Holdings?
Surgalign Holdings all-time high quarterly cash and cash equivalents is $95.79 M
What is Surgalign Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, SRGA quarterly cash and cash equivalents has changed by -$22.25 M (-49.80%)